Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.

Also called NCT06046196

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 148 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06046196
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06046196. Randomized; no masking; primary purpose treatment. Start 2020-11-18 (actual); primary completion 2023-03-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease
Condition
Arterial Occlusive Diseases
Intervention (Drug)
Sarpogrelate SR
Intervention (Drug)
Sarpogrelate
Lead sponsor
Yuhan Corporation (class: industry)

Record details

Record id
cardio:ct-nct06046196
Content hash
c103e169b4a203fac4dd7e210feeab6e7dfb46955032af368f32fb5913d6c0a7